首页|Peking University Shenzhen Hospital Reports Findings in Personalized Medicine (C ommentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma)
Peking University Shenzhen Hospital Reports Findings in Personalized Medicine (C ommentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Drugs and Therapies - Personalized Medicine is the subject of a report. According to news reporting or iginating in Guangdong, People’s Republic of China, by NewsRx journalists, resea rch stated, “Machine learning has made great progress in the field of medicine, especially in oncology research showing significant potential. In this paper, th e application of machine learning in the study of cholangiocarcinoma was discuss ed.”
GuangdongPeople’s Republic of ChinaAsiaCancerCholangiocarcinomaCyborgsDrugs and TherapiesEmerging Technolo giesHealth and MedicineImmunotherapyMachine LearningOncologyPersonaliz ed MedicinePersonalized Therapy
NETL
NSTL
